login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
All US stocks
All Canadian stocks
All European stocks
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
COEPTIS THERAPEUTICS HOLDING (COEP) Stock News
NASDAQ:COEP -
US19207A2078
-
Common Stock
12.66
USD
-0.66 (-4.95%)
Last: 8/28/2025, 4:00:00 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
COEP Latest News, Press Relases and Analysis
All
Press Releases
a month ago - By: Benzinga
- Mentions:
PBM
IRIX
TTNP
HCTI
...
12 Health Care Stocks Moving In Thursday's After-Market Session
a month ago - By: Coeptis Therapeutics
Coeptis (COEP) Extinguishes Convertible Note with YA II PN, Ltd
a month ago - By: Coeptis Therapeutics
Coeptis (COEP) Extinguishes Convertible Note with YA II PN, Ltd
2 months ago - By: Halper Sadeh LLC
- Mentions:
SAGE
AVDX
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SAGE, COEP, AVDX on Behalf of Shareholders
2 months ago - By: Coeptis Therapeutics
Coeptis (COEP) Announces Filing of Registration Statement on Form S-4 with SEC in Connection with Proposed Transaction with Z Squared
2 months ago - By: Coeptis Therapeutics
Coeptis (COEP) Announces Filing of Registration Statement on Form S-4 with SEC in Connection with Proposed Transaction with Z Squared
3 months ago - By: Coeptis Therapeutics
Monarch Therapeutics and SNAP Biosciences, Inc., a Subsidiary of Coeptis Therapeutics Holdings Inc., Enter Licensing Agreement to Bolster SNAP-CAR NK Cell Therapy in Oncology
3 months ago - By: Coeptis Therapeutics
Monarch Therapeutics and SNAP Biosciences, Inc., a Subsidiary of Coeptis Therapeutics Holdings Inc., Enter Licensing Agreement to Bolster SNAP-CAR NK Cell Therapy in Oncology
4 months ago - By: Brodsky & Smith LLC
- Mentions:
SKX
BSGM
PPBI
COLB
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Skechers U.S.A., Inc. (NYSE - SKX), BioSig Technologies, Inc. (Nasdaq – BSGM), Coeptis Therapeutics Holdings, Inc. (Nasdaq – COEP), Pacific Premier Bancorp, Inc.
4 months ago - By: Halper Sadeh LLC
- Mentions:
PPBI
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates COEP and PPBI on Behalf of Shareholders
4 months ago - By: Brodsky & Smith LLC
- Mentions:
KRON
RGLS
PPBI
COLB
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Kronos Bio, Inc. (Nasdaq - KRON), Regulus Therapeutics Inc. (Nasdaq – RGLS), Coeptis Therapeutics Holdings, Inc. (Nasdaq – COEP), Pacific Premier Bancorp, Inc.
4 months ago - By: Benzinga
- Mentions:
RGC
BCLI
ZYXI
RGLS
...
12 Health Care Stocks Moving In Wednesday's Intraday Session
4 months ago - By: Halper Sadeh LLC
- Mentions:
OPTN
SWTX
CKPT
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates OPTN, COEP, SWTX, CKPT on Behalf of Shareholders
4 months ago - By: Halper Sadeh LLC
COEP Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Coeptis Therapeutics Holdings, Inc. Is Fair to Shareholders
4 months ago - By: Coeptis Therapeutics
Coeptis Therapeutics, Inc. and Z Squared Inc. Announce Merger Agreement
4 months ago - By: Coeptis Therapeutics
Coeptis Therapeutics, Inc. and Z Squared Inc. Announce Merger Agreement
4 months ago - By: Coeptis Therapeutics
COEPTIS Partners with NexGenAI Solutions Group to Launch New AI Co-Working Hub in India, Driving Global Innovation in Technology
4 months ago - By: Coeptis Therapeutics
COEPTIS Partners with NexGenAI Solutions Group to Launch New AI Co-Working Hub in India, Driving Global Innovation in Technology
6 months ago - By: Coeptis Therapeutics
Coeptis Therapeutics Secures Worldwide Development and Commercialization Rights to Next-Generation GEAR™ Cell Therapy Platform Strengthening its High-Impact Precision Immuno-Oncology Pipeline
6 months ago - By: Coeptis Therapeutics
Coeptis Therapeutics Secures Worldwide Development and Commercialization Rights to Next-Generation GEAR™ Cell Therapy Platform Strengthening its High-Impact Precision Immuno-Oncology Pipeline
6 months ago - By: Coeptis Therapeutics
COEPTIS’ NexGenAI Affiliates Partners with NUBURU Network to Drive Innovation in AI and Robotics as Part of its Transformation Plan
6 months ago - By: Coeptis Therapeutics
- Mentions:
BURU
COEPTIS’ NexGenAI Affiliates Partners with NUBURU Network to Drive Innovation in AI and Robotics as Part of its Transformation Plan
6 months ago - By: Coeptis Therapeutics
COEPTIS’ NexGenAI Partners with Arketyp Valu to Revolutionize Digital Engagement on the Verus Network
6 months ago - By: Coeptis Therapeutics
COEPTIS’ NexGenAI Partners with Arketyp Valu to Revolutionize Digital Engagement on the Verus Network
6 months ago - By: Coeptis Therapeutics
COEPTIS NexGenAI Affiliates Network & MarketLeverage Announce Strategic Partnership to Revolutionize AI-Powered Affiliate Marketing
6 months ago - By: Coeptis Therapeutics
COEPTIS NexGenAI Affiliates Network & MarketLeverage Announce Strategic Partnership to Revolutionize AI-Powered Affiliate Marketing
6 months ago - By: Coeptis Therapeutics
COEPTIS NexGenAI Affiliates Network & MarketLeverage Announce Strategic Partnership to Revolutionize AI-Powered Affiliate Marketing
6 months ago - By: Coeptis Therapeutics
COEPTIS NexGenAI Affiliates Network & MarketLeverage Announce Strategic Partnership to Revolutionize AI-Powered Affiliate Marketing
Please enable JavaScript to continue using this application.